Medicus Pharma Ltd. MDCX
1.87 USD +0.02 (+1.08%)
At closeNov 9, 2026, 6:24 AM EST
1.74 -0.13 -6.95%
Pre-market · Nov 9, 6:24 AM ET
1.81 Day range 1.95
1.70 52-week range 127.50
- YTD
- -97.56%
- 1 year
- -98.45%
News
benzinga.com Medicus Pharma Q3 EPS $(11.64) Misses $(6.63) Estimate Medicus Pharma (NASDAQ:MDCX) reported quarterly losses of $(11.64) per share which missed the analyst consensus estimate of $(6.63) by 75.83 percent. This is a 79.21 percent increase over losses of…
globenewswire.com Medicus Pharma to Present at BIO-Europe 2026 Medicus Chief Medical Officer will Highlight Company's Focus on Precision Oncology, Anchored by CD228V targeted ADC and Partner Ready Therapeutic Programs Medicus Chief Medical Officer will Highlight…
globenewswire.com Medicus Pharma to Host Third Quarter 2026 Financial Performance and Business Update Call on November 9, 2026 PHILADELPHIA, Nov. 04, 2026 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company"), a precision guided, biotech/life sciences company focused on advancing the clinical…
globenewswire.com Medicus Pharma Announces Proposed SkinJect® Business Combination and Concurrent Financing PHILADELPHIA, Nov. 04, 2026 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) (“Medicus” or the “Company”), a precision guided, biotech/life sciences company focused on advancing novel and…